Drug reimportation: sitting in the middle.

Drug reimportation practices in the United States

BACKGROUND Drug reimportation is perceived as a costs-cutting strategy by Americans. Nonetheless, issues such as drug safety and efficacy prevent legalization of the practice. With the contradictory views from supporters and opponents, debate on drug reimportation continues to snowball. The objective of this commentary is to discuss issues regarding drug reimportation practices in the United St...

Innovation and Drug Reimportation: Cost, Value, and Tradeoffs – Economic, Legal, and Public Policy Implications

Innovation and Drug Reimportation: Cost, Value, and Tradeoffs – Economic, Legal, and Public Policy Implications Based on the proceedings of a University of Michigan Center for Medication Use, Policy and Economics symposium, April 18–20, 2004,Washington, D.C. HIGHLIGHTS • Legislation and Pharmaceutical Reimportation • Price Regulation and Innovation • Price Differentials Between Canada and the U...

A perspective on U.S. drug reimportation.

THE HIGH COST OF PRESCRIPTION DRUGS IN THE UNITED States receives media attention almost daily. In the past year, one third of Americans say that they or a family member has had difficulty paying for medications. A similar proportion has not filled a prescription or has reduced a prescribed dosage because of high out-ofpocket costs. In response, Americans are turning to cheaper sources for thei...

Prescription drug reimportation. Panacea or problem?

Reimportation of Pharmaceuticals: Economic and Policy Implications